Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes.

Saved in:
Bibliographic Details
Title: Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes.
Authors: Alraies Z; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Rivera CA; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Delgado MG; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Sanséau D; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Maurin M; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Amadio R; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Maria Piperno G; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Dunsmore G; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France., Yatim A; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Lacerda Mariano L; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Kniazeva A; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Calmettes V; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Sáez PJ; Cell Communication and Migration Laboratory, Institute of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Williart A; CNRS UMR144, Institut Curie, PSL Research University, Paris, France., Popard H; CNRS UMR144, Institut Curie, PSL Research University, Paris, France., Gratia M; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Lamiable O; Malaghan Institute of Medical Research, Wellington, New Zealand., Moreau A; Center for Research in Transplantation and Translational Immunology, UMR 1064, INSERM, Nantes Université, Nantes, France., Fusilier Z; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France.; INSERM U932, Immunity and Cancer, Institut Curie, Paris-Cité University, Paris, France., Crestey L; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Albaud B; Platform NGS-ICGEX, Institut Curie, Paris, France., Legoix P; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Dejean AS; INSERM UMR1291, CNRS UMR5051, Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITy), Université Toulouse III, Toulouse, France., Le Dorze AL; INSERM UMR1291, CNRS UMR5051, Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITy), Université Toulouse III, Toulouse, France., Nakano H; Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Research Triangle Park, NC, USA., Cook DN; Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Research Triangle Park, NC, USA., Lawrence T; Centre d'Immunologie de Marseille-Luminy, INSERM, CNRS, Université Aix-Marseille, Marseille, France.; Centre for Inflammation Biology and Cancer Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK.; Henan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China., Manel N; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., Benvenuti F; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Ginhoux F; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos, Singapore, Singapore.; Department of Immunology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Moreau HD; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France., P F Nader G; CNRS UMR144, Institut Curie, PSL Research University, Paris, France.; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Piel M; CNRS UMR144, Institut Curie, PSL Research University, Paris, France. matthieu.piel@curie.fr., Lennon-Duménil AM; INSERM U932, Immunity and Cancer, Institut Curie, PSL University, Paris, France. ana-maria.lennon@curie.fr.
Source: Nature immunology [Nat Immunol] 2024 Jul; Vol. 25 (7), pp. 1193-1206. Date of Electronic Publication: 2024 Jun 04.
Publication Type: Journal Article
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/s41590-024-01856-3